Digma.jpg
James-McNally-Digma.jpg
James McNally
CEO

Digma Medical is a clinical stage medical device company developing a novel endoscopic treatment for metabolic disease designed to complement standard medical management.

The Digma System ablates the duodenum to interrupt metabolic signaling pathways, reducing insulin resistance and improving glycemic control.

Our mission is to empower patients and physicians with safe, simple and effective new therapies for metabolic disease that dramatically improve quality of life and long-term health outcomes.

1/1
stripBIG-01.jpg

PORTFOLIO

 
icon-08.png

DEVICES

icon-09.png
icon-07.png

PHARMA & BIOTECH

icon-10.png
icon-06.png

PHARMA & BIOTECH

icon-11.png